Targeted gene delivery via the folate receptor

Polymeric Gene Delivery: Principles and Applications

Volumn , Issue , 2004, Pages 523-535

  Chiu, Shih Jiuan ^a   Lee, Robert J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 14544278621     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203500477     Document Type: Chapter

References (81)

1. Dachs, G.U. et al. Targeting gene therapy to cancer: a review, Oncol. Res. 9, 313, 1997.
2. Walther, W. and Stein, U., Therapeutic genes for cancer gene therapy, Mol. Biotechnol. 13, 21, 1999.
3. Curiel, D.T., Gerritsen, W.R., and Krul, M.R.L., Progress in cancer gene therapy, Cancer Gene Ther. 7, 1197, 2000.
4. Meyer, F. and Finer, M., Gene therapy: progress and challenges, Cell. Mol. Biol. 47, 1277, 2001.
5. Walther, W. and Stein, U., Viral vectors for gene transfer: a review of their use in the treatment of human diseases, Drugs 60, 249, 2000.
6. Seth, P., Adenoviral vectors, in Cancer Gene Therapy: Past Achievements and Future Challenges, Habib, N.A., (Ed.), Kluwer Academic/Plenum Publishers, New York, 2000, chap. 2.
7. Barnett, B.G., Crews, C.J., and Douglas, J.T., Targeted adenoviral vectors, Biochim. Biophys. Acta 1575, 1, 2002.
8. Lasic, D.D. and Templeton, N.S., Liposomes in gene therapy, Adv. Drug Deliv. Rev. 20, 221, 1996.
9. Bilbao, G., et al., Advances in adenoviral vectors for cancer gene therapy, Expert Opin. Ther. Patents 7, 1427, 1997.
10. Rolland, A.P., From genes to gene medicines: recent advances in nonviral gene delivery, Crit. Rev. Ther. Drug Carrier Sys. 15, 143, 1998.
11. Nishikawa, M. and Huang, L., Nonviral vectors in the new millennium: delivery barriers in gene transfer, Hum. Gene Ther. 12, 861, 2001.
12. Wolff, J.A. et al., Direct gene-transfer into mouse muscle in vivo, Science 247, 1465, 1990.
13. Felgner, P.L. et al., Lipofection: a highly efficient, lipid-mediated DNA- transfection procedure, Proc. Nat. Acad. Sci. U.S.A. 84, 7413, 1987.
14. Gao, X. and Huang, L., Potentiation of cationic liposome-mediated gene delivery by polycations, Biochemistry 35, 1027, 1996.
15. Lee, R.J. and Huang, L., Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer, J. Biol. Chem. 271, 8481, 1996.
16. Li, S. et al., Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery, Gene Ther. 5, 930, 1998.
17. Hart, S.L., Synthetic vectors for gene therapy, Expert Opin. Ther. Patents 10, 199, 2000.
18. De Smedt, S.C., Demeester, J., and Hennink, W.E., Cationic polymer based gene delivery systems, Pharm. Res. 17, 113, 2000.
19. Pouton, C.W. and Seymour, L.W., Key issues in non-viral gene delivery, Adv. Drug Del. Rev. 46, 187, 2001.
20. Schatzlein, A.G., Non-viral vectors in cancer gene therapy: principles and progress, Anti-Cancer Drugs 12, 275, 2001.
21. Segura, T. and Shea, L.D., Materials for non-viral gene delivery, Ann. Rev. Mater. Res. 31, 25, 2001.
22. Merdan, T., Kopecek, J., and Kissel, T., Prospects for cationic polymers in gene and oligonucleotide therapy against cancer, Adv. Drug Del. Rev. 54, 715, 2002.
23. Niidome, T. and Huang, L., Gene therapy progress and prospects: Nonviral vectors, Gene Ther. 9, 1647, 2002.
24. Wiethoff, C.M. and Middaugh, C.R., Barriers to nonviral gene delivery, J. Pharm. Sci. 92, 203, 2003.
25. Lacey, S.W. et al., Complementary-DNA for the folate binding-protein correctly predicts anchoring to the membrane by glycosyl- phosphatidylinositol, J. Clin. Invest. 84, 715, 1989.
26. Ratnam, M. et al., Homologous membrane folate binding-proteins in human-placenta: cloning and sequence of a cDNA, Biochemistry 28, 8249, 1989.
27. Shen, F. et al., Identification of a novel folate receptor, a truncated receptor, and receptor-type-beta in hematopoietic-cells: cDNA cloning, expression, immunoreactivity, and tissue-specificity, Biochemistry 33, 1209, 1994.
28. Shen, F. et al., Folate receptor-type-gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell-type specificity, Biochemistry 34, 5660, 1995.
29. Antony, A.C., The biological chemistry of folate receptors, Blood 79, 2807, 1992.
30. Sirotnak, F.M. and Tolner, B., Carrier-mediated membrane transport of folates in mammalian cells, Annu. Rev. Nutr. 19, 91, 1999.
31. Weitman, S.D. et al., Distribution of the folate receptor gp38 in normal and malignant-cell lines and tissues, Cancer Res. 52, 3396, 1992.
32. Garinchesa, P. et al., Trophoblast and ovarian-cancer antigen-LK26: sensitivity and specificity in immunopathology and molecular-identification as a folate-binding protein, Am. J. Pathol. 142, 557, 1993.
33. Ross, J.F. et al., Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia, Cancer 85, 348, 1999.
34. Toffoli, G. et al., Overexpression of folate binding protein in ovarian cancers, Int. J. Cancer 74, 193, 1997.
35. Antony, A.C., Folate receptors, Annu. Rev. Nutr. 16, 501, 1996.
36. Christensen, E.I. et al., Membrane receptors for endocytosis in the renal proximal tubule, Int. Rev. Cytol. 180, 237, 1998.
37. Brzezinska, A., Winska, P., and Balinska, M., Cellular aspects of folate and antifolate membrane transport, Acta Biochim. Pol. 47, 735, 2000.
38. Molthoff, C.F. et al., Radioimmunotherapy of ovarian cancer with intravenously administered iodine-131 labeled chimeric MOv18 monoclonal antibody, J. Nuclear Med. 40, 966, 1999.
39. van Zanten-Przybysz, I. et al., Radioimmunotherapy with intravenously administered i-131-labeled chimeric monoclonal antibody MOv18 in patients with ovarian cancer, J. Nuclear Med. 41, 1168, 2000.
40. Kranz, D.M. et al., Conjugates of folate and anti-T-cell-receptor antibodies specifically target folatereceptor- positive tumor-cells for lysis, Proc. Nat. Acad. Sci. U.S.A. 92, 9057, 1995.
41. Hwu, P. et al., In vivo antitumor-activity of T-cells redirected with chimeric antibody T-cell receptor genes, Cancer Res. 55, 3369, 1995.
42. Gabizon, A. et al., Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)- grafted liposomes: in vitro studies, Bioconj. Chem. 10, 289, 1999.
43. Leamon, C.P. and Low, P.S., Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis, Proc. Nat. Acad. Sci. U.S.A. 88, 5572, 1991.
44. Leamon, C.P. and Low, P.S., Cytotoxicity of momordin-folate conjugates in cultured human cells, J. Biol. Chem. 267, 24966, 1992.
45. Leamon, C.P., Pastan, I., and Low, P.S., Cytotoxicity of folate-pseudomonas exotoxin conjugates toward tumor-cells: contribution of translocation domain, J. Biol. Chem. 268, 24847, 1993.
46. Atkinson, S.F. et al., Conjugation of folate via gelonin carbohydrate residues retains ribosomalinactivating properties of the toxin and permits targeting to folate receptor positive cells, J. Biol. Chem. 276, 27930, 2001.
47. Lu, J.Y. et al., Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug, J. Drug Target. 7, 43, 1999.
48. Melani, C. et al., Targeting of Interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody, Cancer Res. 58, 4146, 1998.
49. Mathias, C.J. et al., Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate, J. Nuclear Med. 37, 1003, 1996.
50. Guo, W., Hinkle, G.H., and Lee, R.J., 99mTc-HYNIC-folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging, J. Nuclear Med. 40, 1563, 1999.
51. Lee, R.J. and Low, P.S., Folate-mediated tumor-cell targeting of liposome-entrapped doxorubicin in vitro, Biochim. Biophys. Acta 1233, 134, 1995.
52. Ladino, C.A. et al., Folate-maytansinoids: target-selective drugs of low molecular weight, Int. J. Cancer 73, 859, 1997.
53. Konda, S.D. et al., Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts, Magn. Reson. Mater. Phys. Biol. Med. 12, 104, 2001.
54. Lee, R.J. and Low, P.S., Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis, J. Biol. Chem. 269, 3198, 1994.
55. Wang, S., et al., Delivery of antisense oligodeoxyribonucleotides against the human epidermal growthfactor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene-glycol, Proc. Nat. Acad. Sci. U.S.A. 92, 3318, 1995.
56. Gottschalk, S. et al., Folate receptor-mediated DNA delivery into tumor-cells - potosomal disruption results in enhanced gene-expression, Gene Ther. 1, 185, 1994.
57. Douglas, J.T. et al., Targeted gene delivery by tropism-modified adenoviral vectors, Nat. Biotechnol. 14, 1574, 1996.
58. Wang, S. and Low, P.S., Folate-mediated targeting of antineoplastic drags, imaging agents, and nucleic acids to cancer cells, J. Control. Release 53, 39, 1998.
59. Benns, J.M. and Kim, S.W., Tailoring new gene delivery designs for specific targets, J. Drug Target. 8, 1, 2000.
60. Sudimack, J. and Lee, R.J., Targeted drug delivery via the folate receptor, Adv. Drug Del. Rev. 41, 147, 2000.
61. Leamon, C.P. and Low, P.S., Folate-mediated targeting: from diagnostics to drug and gene delivery, Drug Discov. Today 6, 44, 2001.
62. Lu, Y.J. and Low, P.S., Folate-mediated delivery of macromolecular anticancer therapeutic agents, Adv. Drug Del. Rev. 54, 675, 2002.
63. Gosselin, M.A. and Lee, R.J., Folate receptor-targeted liposomes as vectors for therapeutic agents, in Biotechnology Annual Review, El-Gewely, M.R. (Ed.), Elsevier Science, Amsterdam, 2002, 103.
64. Guo, W.J. et al., Receptor-specific delivery of liposomes via folate-PEG-Chol, J. Liposome Res. 10, 179, 2000.
65. Reddy, J.A. and Low, P.S., Folate-mediated targeting of therapeutic and imaging agents to cancers, Crit. Rev. Ther. Drug Carrier Sys. 15, 587, 1998.
66. Ward, C.M., Folate-targeted non-viral DNA vectors for cancer gene therapy, Curr. Opin. Mol. Ther. 2, 182, 2000.
67. Reddy, J.A., Clapp, D.W., and Low, P.S., Retargeting of viral vectors to the folate receptor endocytic pathway, J. Control. Release 74, 77, 2001.
68. Douglas, J.T. and Curiel, D.T., Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors, Neuromusc. Disord. 7, 284, 1997.
69. Mislick, K.A. et al., Transfection of folate-polylysine DNA complexes - evidence for lysosomal delivery, Bioconj. Chem. 6, 512, 1995.
70. Leamon, C.P., Weigl, D., and Hendren, R.W., Folate copolymer-mediated transfection of cultured cells, Bioconj. Chem. 10, 947, 1999.
71. Ward, C.M. et al., Modification of PLL/DNA complexes with a multivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged plasma circulation in vivo, J. Gene Med. 4, 536, 2002.
72. Guo, W.J. and Lee, R.J., Receptor-targeted gene delivery via folate-conjugated polyethylenimine, AAPS Pharmsci. 1, Article 19, 1999.
73. Benns, J.M. et al., Folate-PEG-folate-graft-polyethylenimine-based gene delivery, J. Drug Target. 9, 123, 2001.
74. Benns, J.M., Mahato, R.I., and Kim, S.W., Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine, J. Control. Release 79, 255, 2002.
75. van Steenis, J.H. et al., Preparation and characterization of folate-targeted PEG-coated pDMAEMAbased polyplexes, J. Control. Release 87, 167, 2003.
76. Dauty, E. et al., Intracellular delivery of nanometric DNA particles via the folate receptor, Bioconj. Chem. 13, 831, 2002.
77. Hofland, H.E.J. et al., Folate-targeted gene transfer in vivo, Mol. Ther. 5, 739, 2002.
78. Reddy, J.A. et al., Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors, Gene Ther. 9, 1542, 2002.
79. Reddy, J.A. et al., Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy, J. Pharm. Sci. 88, 1112, 1999.
80. Reddy, J.A. and Low, P.S., Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation, J. Control. Release 64, 27, 2000.
81. Gosselin, M.A., Guo, W.J., and Lee, R.J., Incorporation of reversibly cross-linked polyplexes into LPDII vectors for gene delivery, Bioconj. Chem. 13, 1044, 2002.